CNBX PHARMACEUTICALS INC. (CNBX) Total liabilities 2016–2025
CNBX PHARMACEUTICALS INC. (CNBX) total liabilities at each fiscal year-end, per SEC filings.
$2.5MFY2025 · since FY2016: $491,164 → $2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5M | +0.1% |
| FY2024 | $2.5M | -0.2% |
| FY2023 | $2.5M | +406.4% |
| FY2022 | -$821,145 | -164.5% |
| FY2021 | $1.3M | +179.9% |
| FY2020 | $454,787 | +3.6% |
| FY2019 | $438,874 | -18.6% |
| FY2018 | $539,382 | -91.8% |
| FY2017 | $6.6M | +1238.9% |
| FY2016 | $491,164 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CNBX financial trends
CNBX RevenueCNBX Net incomeCNBX Net marginCNBX Gross profitCNBX Gross marginCNBX Operating incomeCNBX Operating marginCNBX Operating cash flowCNBX Free cash flowCNBX Capital expendituresCNBX Return on equityCNBX Stock buybacksCNBX Dividends paidCNBX Total assetsCNBX Shareholders’ equityCNBX overview →